Latest round: IPO. Magnus Corfitzen is the Chief Executive Officer of Ascelia Pharma, a biotech company focused on orphan oncology treatments.
Magnus Corfitzen is the Chief Executive Officer of Ascelia Pharma, a biotech company focused on orphan oncology treatments. He joined the company in 2014. Previously, Corfitzen held roles as Investment Director at Sunstone Capital A/S and Vækstfonden (the Danish Growth Fund), and as a Portfolio Manager at Danske Capital, specializing in listed biotech and medtech companies. He began his career at McKinsey & Company.
Full founder directory · Investor directory · Company funding database · Fundraising library